Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-26-003076

Director sold 2,500 shares at $35.00 ($87,500)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ali-Jackson Kamil · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-22 Sale : show line 1 in the form 10b5-1 −2,500 $35.00 $87,500 10,125 D
Open-market sales · 2,500 sh · avg $35.00 · $87,500
Loading xslF345X06/form4.xml…